Table 1.
Analgesic, adjuvant, and psychiatric medication use in the previous two weeks by participants reporting chronic pain, MOBILIZE Boston study 2005–2008
| Medication use | Total (n=599) n (%) |
Pain Severity Group | |||
|---|---|---|---|---|---|
| Very Mild (n=210) n (%) |
Mild (n=200) n (%) |
Moderate-Severe (n=189) n (%) |
P valuea | ||
| Analgesic medicationsb | |||||
| None | 294(49.1) | 142 (67.6) | 93 (46.5) | 59(31.2) | |
| < 1 daily | 131 (21.9) | 45 (21.4) | 49 (24.5) | 37(19.6) | |
| > 1 daily | 174 (29.0) | 23 (11.0) | 58 (29.0) | 93 (49.2) | <0.0001 |
| Opioid analgesic medications | |||||
| None | 554 (92.5) | 209 (99.5) | 189 (94.5) | 156 (82.5) | |
| < 1 daily | 17 (2.8) | 1 (0.5) | 4 (2.0) | 12(6.4) | |
| > 1 daily | 24 (4.7) | 0 (0.0) | 7 (3.5) | 21(11.1) | <0.0001 |
| Non-opioid analgesic medicationsc | |||||
| None | 302 (50.4) | 143 (68.1) | 96 (48.0) | 63 (33.3) | |
| < 1 daily | 130 (21.7) | 44 (20.9) | 49 (24.5) | 37 (19.6) | |
| ≥ 1 daily | 167 (27.8) | 23 (11.0) | 55 (27.5) | 89 (47.1) | <0.0001 |
| Adjuvant analgesic medicationsd | |||||
| None | 537 (89.6) | 194(92.4) | 186 (93.0) | 157 (83.1) | |
| < 1daily | 3 (0.5) | 2 (0.9) | 0 (0.0) | 1 (0.5) | |
| > 1daily | 59 (9.9) | 14 (6.7) | 14 (7.0) | 31 (16.4) | 0.004 |
| Psychiatric medicationse | |||||
| None | 462 (77.1) | 170 (80.9) | 147 (73.5) | 145 (76.7) | |
| <1 daily | 24 (4.0) | 10 (4.8) | 11 (5.5) | 3 (1.6) | |
| >1daily | 113 (18.9) | 30(14.3) | 42 (21.0) | 41(21.7) | 0.07 |
a
Chi square test for overall differences (4–6 df)
b
Includes all analgesic classes
c
Includes acetaminophen, non-steroidal anti-inflammatory drugs, and aspirin (except low dose aspirin for cardio prevention)
d
Includes antidepressants (amitriptyline, fluoxetine, venlafaxine, duloxetine), anticonvulsants (gabapentin, carbamazepin, levetiracetran, lamotrigine), and corticosteroids (prednisolone, fludrocortisones, methyprednisolone)
e
Includes antidepressant (non-adjuvant such as trazadone), and anxiolytic medication